Cargando…

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19

Coronaviruses are positive sense, single-stranded, enveloped, and non-segmented RNA viruses that belong to the Coronaviridae family within the order Nidovirales and suborder Coronavirinae. Two Alphacoronavirus strains: HCoV-229E and HCoV-NL63 and five Betacoronaviruses: HCoV-HKU1, HCoV-OC43, SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Homa Nath, Latimore, Charity O. D., Matthews, Qiana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470303/ https://www.ncbi.nlm.nih.gov/pubmed/34578250 http://dx.doi.org/10.3390/pathogens10091218

Ejemplares similares

A SARS-CoV-2: Companion Animal Transmission and Variants Classification
por: Pandit, Rachana, et al.
Publicado: (2023)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
por: Kang, Yeon-Woo, et al.
Publicado: (2021)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
por: Zhou, Shilin, et al.
Publicado: (2023)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Current understanding of T cell immunity against SARS-CoV-2
por: Lu, Xiuyuan, et al.
Publicado: (2022)

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice
por: Schäfer, Alexandra, et al.
Publicado: (2022)

Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Structural biology of SARS-CoV-2 and implications for therapeutic development
por: Yang, Haitao, et al.
Publicado: (2021)

Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection
por: Sahu, Utkarsha, et al.
Publicado: (2021)

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
por: Lee, Eunjin, et al.
Publicado: (2021)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

Sensitive detection of anti‐spike antibodies enables improved understanding of SARS‐CoV‐2 pathogenesis
por: Milling, Simon
Publicado: (2021)

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
por: Zhang, Jiantao, et al.
Publicado: (2022)

Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
por: Kumar, Nilesh, et al.
Publicado: (2020)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
por: Bunders, Madeleine J., et al.
Publicado: (2020)

Understanding variants of SARS-CoV-2
por: Burki, Talha
Publicado: (2021)

Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2
por: Khan, Mohammad Mansoob, et al.
Publicado: (2022)

Discovering small-molecule therapeutics against SARS-CoV-2
por: Tiwari, Vaibhav, et al.
Publicado: (2020)

Natural therapeutics against SARS CoV2: the potentiality and challenges
por: Bhar, Anirban, et al.
Publicado: (2022)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
por: Bhat, Swati, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics
por: Walsh, Martin A., et al.
Publicado: (2021)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
por: Khalaf, Khalil, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Substances of abuse and their effect on SAR-CoV-2 pathogenesis
por: Antwi, Ivy, et al.
Publicado: (2023)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
por: Pang, Natalie Yan-Lin, et al.
Publicado: (2021)

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
por: Tang, Qilong, et al.
Publicado: (2021)

Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2
por: Zhao, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8t3v0hvj01lt4a4irhorhrvb7r